Showing results (271-280 of 1,757) with videos related to

Sort By:
Pageof 176
Vascular Pharmacology|August 4, 2025
Resolvin D2 limits senescent cell accumulation in atherosclerotic plaquesMasharh Lipscomb, Ignacia Salfate Del Rio, Maya Eid, et al.
Vascular Pharmacology|July 27, 2025
Translational aspects of doxorubicin-induced cardiotoxicity: What we have omitted for the past decades?Ashot Avagimyan, Rosalinda Madonna, Mohammad Sheibani, et al.
Vascular Pharmacology|August 12, 2014
Disturbance of vasodilation via protease-activated receptor 2 in SHRSP.Z-Lepr fa/IzmDmcr rats with metabolic syndromeSatomi Kagota, Kana Maruyama, Hirokazu Wakuda, et al.
Vascular Pharmacology|May 21, 2013
Agonistic anti-ICAM-1 antibodies in scleroderma: activation of endothelial pro-inflammatory cascadesSabine I Wolf, Sarah Howat, David J Abraham, et al.
Vascular Pharmacology|April 23, 2013
Vasorelaxant and antihypertensive effects of methanolic fraction of the essential oil of Alpinia zerumbetGilmara Holanda da Cunha, Manoel Odorico de Moraes, Francisco Vagnaldo Fechine, et al.
Vascular Pharmacology|March 8, 2013
Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell lineMandy M Y Tse, Mona E Aboutabl, Hassan N Althurwi, et al.
Vascular Pharmacology|February 6, 2013
Connective tissue growth factor (CCN2) in blood vesselsMarkella Ponticos
Vascular Pharmacology|February 2, 2013
Restoring stem cell mobilization to promote vascular repair in diabetesMattia Albiero, Angelo Avogaro, Gian Paolo Fadini
Vascular Pharmacology|December 27, 2012
Murine atrial HL-1 cell line is a reliable model to study drug metabolizing enzymes in the heartOsama H Elshenawy, Anwar Anwar-Mohamed, Ghada Abdelhamid, et al.
Vascular Pharmacology|December 4, 2012
An in vitro investigation of the cardiovascular effects of the 5-HT(4) receptor selective agonists, velusetrag and TD-8954D T Beattie, D L Higgins, M P Ero, et al.
Pageof 176